Articles
| Open Access |
https://doi.org/10.55640/
CARDIOVASCULAR DISEASES (E.G., HYPERTENSION, HEART ATTACK)
Abdunabieva Khakimakhon Muhtarovna , Assistant of Andijan State Medical Institute,UzbekistanAbstract
Cardiovascular diseases (CVDs), including hypertension and heart attacks, continue to be leading causes of morbidity and mortality worldwide. These diseases affect millions of people, resulting in significant healthcare burdens. Understanding the risk factors, pathophysiological mechanisms, and the available therapeutic strategies is crucial for addressing the global prevalence of cardiovascular diseases. This article provides an overview of hypertension and heart attacks, focusing on their prevalence, causes, treatments, and the latest research findings. A comprehensive review of current knowledge and data is discussed, with a particular emphasis on recent advancements in prevention and treatment.
Keywords
Cardiovascular diseases, hypertension, heart attack, risk factors, treatment strategies, prevention, healthcare burden
References
World Health Organization. (2021). "Hypertension." World Health Organization. Retrieved from https://www.who.int/news-room/fact-sheets/detail/hypertension
Wright, J. M., et al. (2020). "Lifestyle interventions to reduce blood pressure: a meta-analysis." The Lancet, 395(10237), 347-354.
Jackson, G., et al. (2021). "Pharmacological treatment of hypertension: an overview." Journal of Hypertension, 39(4), 729-738.
Global Burden of Disease Study 2018. (2018). "Global causes of death in 2018." The Lancet, 392(10159), 1736-1788.
Libby, P., et al. (2019). "Inflammation and atherosclerosis." Circulation Research, 124(3), 386-399.
Zhan, L., et al. (2022). "Increasing trends in myocardial infarction rates in young adults." Circulation, 145(2), 102-113.
Mozaffarian, D., et al. (2019). "Impact of improved treatment on myocardial infarction mortality: A meta-analysis." Circulation, 140(7), 588-596.
Article Statistics
Downloads
Copyright License

This work is licensed under a Creative Commons Attribution 4.0 International License.